KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Castle Biosciences (CSTL) Total Current Liabilities (2018 - 2026)

Castle Biosciences' Total Current Liabilities history spans 8 years, with the latest figure at $68.7 million for Q4 2025.

  • On a quarterly basis, Total Current Liabilities rose 39.04% to $68.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $68.7 million, a 39.04% increase, with the full-year FY2025 number at $68.7 million, up 39.04% from a year prior.
  • Total Current Liabilities hit $68.7 million in Q4 2025 for Castle Biosciences, up from $55.3 million in the prior quarter.
  • Over the last five years, Total Current Liabilities for CSTL hit a ceiling of $68.7 million in Q4 2025 and a floor of $17.6 million in Q1 2021.
  • Historically, Total Current Liabilities has averaged $37.1 million across 5 years, with a median of $36.2 million in 2022.
  • Biggest five-year swings in Total Current Liabilities: crashed 33.95% in 2021 and later surged 124.83% in 2022.
  • Tracing CSTL's Total Current Liabilities over 5 years: stood at $24.9 million in 2021, then skyrocketed by 45.17% to $36.1 million in 2022, then soared by 31.94% to $47.7 million in 2023, then grew by 3.62% to $49.4 million in 2024, then soared by 39.04% to $68.7 million in 2025.
  • Business Quant data shows Total Current Liabilities for CSTL at $68.7 million in Q4 2025, $55.3 million in Q3 2025, and $50.9 million in Q2 2025.